Publication | Closed Access

Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: Feasibility and tolerability in a subset of patients in a randomized trial

Breast OncologyOncologyWomen 60Breast CancerRandomized TrialCancer TreatmentMedicineRadiation OncologyDose-dense Adjuvant Chemotherapy